ixazomib api

Ixazomib Citrate (1201902-80-8) Ixazomib citrate is a proteasome inhibitor that prevents cell growth in solid tumours. This anti-cancer agent is specifically used for the treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate demonstrates superior pharmacokinetics, efficacy, and anticancer activity. Key Features Proteasome inhibitor for cancer treatment Specifically indicated for multiple myeloma Superior pharmacokinetics compared to bortezomib Enhanced